Literature DB >> 9649220

Circulating antibodies to the 60-kD heat shock protein (hsp) family in patients with Helicobacter pylori infection.

S G Barton1, V R Winrow, D S Rampton, J E Crabtree, I L Beales, J Calam.   

Abstract

Whilst the mechanism by which Helicobacter pylori causes different gastroduodenal diseases is uncertain, strains producing the cytotoxin-associated protein (CagA) have greater pathogenicity. Hsps are immunogenic molecules induced by inflammatory mediators. The aim of this study was to assess pathogenicity of hsp antibodies in H. pylori-infected patients. ELISA techniques were used to assay sera of H. pylori-positive patients with gastritis, gastric atrophy, duodenal or gastric ulcer, and H. pylori-negative controls, for antibodies to CagA and to human, mycobacterial, and in 20 sera, H. pylori (hspB) 60-kD hsp. IgA antibodies to mycobacterial hsp60 in atrophy patients were elevated compared with patients with gastritis (P < 0.05) and with H. pylori-negative controls (P < 0.0005). IgA antibodies to human hsp60 in gastric atrophy patients were elevated compared with H. pylori-negative controls (P < 0.05). Patients with atrophy (P < 0.0005) and gastritis (P < 0.05) who were CagA-positive had raised titres of anti-mycobacterial hsp60 IgA antibodies compared with controls. IgA antibody levels to hspB were positively correlated with those to mycobacterial hsp60 (mhsp60) (P < 0.05) and human hsp60 (hhsp60) (P < 0.005). IgA antibodies to hsp60 are associated with gastroduodenal disease, particularly gastric atrophy, in H. pylori-infected patients. Increased humoral responses to hsp60 could either contribute to gastric atrophy or result from greater gastric mucosal damage induced by CagA-positive strains of H. pylori.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9649220      PMCID: PMC1904999          DOI: 10.1046/j.1365-2249.1998.00608.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

Review 1.  Molecular chaperones.

Authors:  R J Ellis; S M van der Vies
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

Review 2.  Stress proteins, autoimmunity, and autoimmune disease.

Authors:  J B Winfield; W N Jarjour
Journal:  Curr Top Microbiol Immunol       Date:  1991       Impact factor: 4.291

3.  Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology.

Authors:  J E Crabtree; J D Taylor; J I Wyatt; R V Heatley; T M Shallcross; D S Tompkins; B J Rathbone
Journal:  Lancet       Date:  1991-08-10       Impact factor: 79.321

4.  Disease association of antibodies to human and mycobacterial hsp70 and hsp60 stress proteins.

Authors:  A Elsaghier; C Prantera; G Bothamley; E Wilkins; S Jindal; J Ivanyi
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

5.  Identification and purification of a cpn60 heat shock protein homolog from Helicobacter pylori.

Authors:  B E Dunn; R M Roop; C C Sung; S A Sharma; G I Perez-Perez; M J Blaser
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

6.  Primary structure of a human mitochondrial protein homologous to the bacterial and plant chaperonins and to the 65-kilodalton mycobacterial antigen.

Authors:  S Jindal; A K Dudani; B Singh; C B Harley; R S Gupta
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

7.  Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection.

Authors:  I L Beales; J E Crabtree; D Scunes; A Covacci; J Calam
Journal:  Eur J Gastroenterol Hepatol       Date:  1996-07       Impact factor: 2.566

8.  Heterologous expression of the 65-kilodalton antigen of Mycobacterium leprae and murine T-cell responses to the gene product.

Authors:  F I Lamb; A E Kingston; I Estrada; M J Colston
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

9.  Urease-associated heat shock protein of Helicobacter pylori.

Authors:  D J Evans; D G Evans; L Engstrand; D Y Graham
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

10.  Raised serum IgG and IgA antibodies to mycobacterial antigens in rheumatoid arthritis.

Authors:  G Tsoulfa; G A Rook; J D Van-Embden; D B Young; A Mehlert; D A Isenberg; F C Hay; P M Lydyard
Journal:  Ann Rheum Dis       Date:  1989-02       Impact factor: 19.103

View more
  7 in total

Review 1.  Extradigestive manifestations of Helicobacter pylori infection: fact and fiction.

Authors:  G Realdi; M P Dore; L Fastame
Journal:  Dig Dis Sci       Date:  1999-02       Impact factor: 3.199

2.  Helicobacter pylori's virulence and infection persistence define pre-eclampsia complicated by fetal growth retardation.

Authors:  Simona Cardaropoli; Alessandro Rolfo; Annalisa Piazzese; Antonio Ponzetto; Tullia Todros
Journal:  World J Gastroenterol       Date:  2011-12-21       Impact factor: 5.742

3.  Immunoglobulin G1 antibody response to Helicobacter pylori heat shock protein 60 is closely associated with low-grade gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  E Ishii; K Yokota; T Sugiyama; Y Fujinaga; K Ayada; I Hokari; S Hayashi; Y Hirai; M Asaka; K Oguma
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

4.  Effect of jianpiyiqi prescription on the expression of heat shock proteins in acetic acid-induced chronic gastric ulcer rats.

Authors:  X Tao; G Li; S Luo
Journal:  J Tongji Med Univ       Date:  2001

5.  Serum antibodies to Helicobacter hepaticus and Helicobacter pylori in patients with chronic liver disease.

Authors:  I Nilsson; S Lindgren; S Eriksson; T Wadström
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

6.  Evaluation of a commercial immunoblot, Helicoblot 2.1, for diagnosis of Helicobacter pylori infection.

Authors:  Lea Veijola; Aino Oksanen; Pentti Sipponen; Hilpi Rautelin
Journal:  Clin Vaccine Immunol       Date:  2008-09-30

7.  Performances of Four Helicobacter pylori Serological Detection Kits Using Stool Antigen Test as Gold Standard.

Authors:  Susheela D Biranjia-Hurdoyal; Sharmila P Seetulsingh-Goorah
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.